Anti-Jo-1 antibodies

被引:55
|
作者
Zampieri, S [1 ]
Ghirardello, A [1 ]
Iaccarino, L [1 ]
Tarricone, E [1 ]
Gambari, PF [1 ]
Doria, A [1 ]
机构
[1] Univ Padua, Dept Med & Surg Sci, Div Rheumatol, Padua, Italy
关键词
idiopathic inflammatory myopathy; polymyositis; histidyl-tRNA synthetase; anti-Jo-1; antibody; anti-synthetase syndrome;
D O I
10.1080/08916930400022640
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Anti-Jo-1 antibody is a myositis specific autoantibody most commonly found in patients with idiopathic inflammatory myopathies (IIM). This antibody is directed against the histidyl-tRNA synthetase which catalyses the binding of the histidine to its cognate tRNA during protein synthesis. It can be considered a specific marker of IIM, predominantly found in 20-30% of patients with PM and in the 60-70% of those with interstitial pulmonary fibrosis. These antibodies are also found in DM, although less frequently than in PM, and are rare in children with PM or DM and in other connective tissue diseases. ELISA, CIE and immunoblotting are highly specific and sensitive techniques for testing anti-Jo-1 antibodies. The detection of this antibody is particularly useful in diagnosis and classification of IIM. Moreover, anti-Jo-1 serum levels strongly correlate with disease activity representing a good marker for disease monitoring.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [41] Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy
    Rutjes, SA
    Egberts, WTMV
    Jongen, P
    VandenHoogen, F
    Pruijn, GJM
    VanVenrooij, WJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01): : 32 - 40
  • [42] A SUBLUXING ARTHROPATHY ASSOCIATED WITH THE ANTI-JO-1 ANTIBODY IN POLYMYOSITIS DERMATOMYOSITIS
    ODDIS, CV
    MEDSGER, TA
    COOPERSTEIN, LA
    ARTHRITIS AND RHEUMATISM, 1990, 33 (11): : 1640 - 1645
  • [43] A unique autoantibody pattern of positive anti-Jo-1, anti-U1RNP, and antiproteasome antibodies in autoimmune myositis as a diagnostic challenge
    Feist, E
    Schneider, ML
    Brychcy, M
    Dörner, T
    Burmester, GR
    Hiepe, F
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (04) : 370 - 371
  • [44] Reply: Perifascicular necrosis in anti-synthetase syndrome beyond anti-Jo-1
    Allenbach, Yves
    Hervier, Baptise
    Stenzel, Werner
    Benveniste, Olivier
    BRAIN, 2016, 139
  • [45] Differences in the Clinical Characteristics and 1-Year Mortality Rates of Patients with Dermatomyositis with anti-Jo-1 and anti-MDA5 Antibodies
    Liu, Chao-Han
    Kor, Chew-Teng
    Hung, Ming-Hui
    Hsiao, Kai-Hung
    Cheng, Yen-Huang
    Tien, Ya-Chih
    JOURNAL OF IMMUNOLOGY RESEARCH, 2023, 2023
  • [46] COVID-19 vaccination-associated anti-Jo-1 syndrome
    Gupta, Kushagra
    Sharma, Gauri Shankar
    Kumar, Ashok
    REUMATOLOGIA, 2021, 59 (06): : 420 - 422
  • [47] Anti-Jo-1 antibody positive polymyositis-successful therapy with leflunomide
    Lange, Uwe
    Piegsa, Manfred
    Mueller-Ladner, Ulf
    Strunk, Johannes
    AUTOIMMUNITY, 2006, 39 (03) : 261 - 264
  • [48] Anti-Jo-1 autoantibodies aid in differentiating facioscapulohumeral dystrophy from polymyositis
    Hengstman, GJD
    van der Kooi, EL
    Egberts, WTMV
    van Venrooij, WJ
    van Engelen, BGM
    NEUROLOGY, 2004, 62 (07) : A500 - A500
  • [49] Acute respiratory distress syndrome in a polymyositis patient with the anti-Jo-1 antibody
    Tomsic, M
    Sifrer, F
    WIENER KLINISCHE WOCHENSCHRIFT, 2000, 112 (15-16) : 728 - 731
  • [50] Anti-Jo-1 autoantibodies: biomarkers of severity and evolution of the disease in antisynthetase syndrome
    Arcani, Robin
    Rey, Louise
    Mazziotto, Alice
    Bertin, Daniel
    Kaplanski, Gilles
    Jarrot, Pierre-Andre
    Lafforgue, Pierre
    Venton, Geoffroy
    Heim, Xavier
    Villani, Patrick
    Mege, Jean-Louis
    Brodovitch, Alexandre
    Bardin, Nathalie
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)